Literature DB >> 923734

Mitogenic action of neuraminidase.

G Semenzato, P Sarasin, G Amadori, G Gasparotto.   

Abstract

A new effect of NCV on lymphocytes is demonstrated. This property is the capacity to act as a mitogen in and of itself. The possible mechanisms of this phenomenon are discussed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 923734     DOI： 10.1007/bf01918846

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  16 in total

1.  Neuraminidase "unmasking" and failure of trypsin to "unmask" -D-galactose-like sites on erythrocyte, lymphoma, and normal and virus-transformed fibroblast cell membranes.

Authors:  G L Nicolson
Journal:  J Natl Cancer Inst       Date:  1973-06       Impact factor: 13.506

2.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

3.  Mitogenic action of papain.

Authors:  D Mazzei; C Novi; C Bazzi
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

4.  Mitogenic action of trypsin and chymotrypsin.

Authors:  D Mazzei; C Novi; C Bazzi
Journal:  Lancet       Date:  1966-07-23       Impact factor: 79.321

Review 5.  Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Report of a WHO-IARC-sponsored workshop on human B and T cells, London, 15-17 July 1974.

Authors: 
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

6.  Enhancement of delayed skin hypersensitivity by neuraminidase in cancer patients.

Authors:  T Han
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

7.  The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.

Authors:  P K Ray; H Gewurz; R L Simmons
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

8.  Transformation of human peripheral lymphocytes by galactose oxidase.

Authors:  J F Dixon; J W Parker; R L O'Brien
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

9.  [Lymphocytes HLA antigens expressivity after neuraminidase treatment (author's transl)].

Authors:  A de Mouzon; E Ohayon; F Oksman-Domejean; J Ducos
Journal:  Ann Immunol (Paris)       Date:  1976 Sep-Oct

10.  Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells.

Authors:  Z Bentwich; S D Douglas; E Skutelsky; H G Kunkel
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307
View more
  2 in total

1.  [Glycoproteins: their biological and clinical significance. II (author's transl)].

Authors:  E Köttgen; C Bauer; W Reutter; W Gerok
Journal:  Klin Wochenschr       Date:  1979-03-01

2.  Enhancement of T-cell response to PWM by neuraminidase-treated non-T cells.

Authors:  T Sakano
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.